Found: 10
Select item for more details and to access through your institution.
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00941-w
- By:
- Publication type:
- Article
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0305285
- By:
- Publication type:
- Article
Scientific approaches toward improving cervical cancer elimination strategies.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 9, p. 1537, doi. 10.1002/ijc.34839
- By:
- Publication type:
- Article
HPV16 E6‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 6, p. 1313, doi. 10.1002/ijc.34614
- By:
- Publication type:
- Article
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised HPV vaccination trial with moderate coverage.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 12, p. 3511, doi. 10.1002/ijc.33169
- By:
- Publication type:
- Article
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 440, doi. 10.1002/ijc.32802
- By:
- Publication type:
- Article
Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 785, doi. 10.1002/ijc.32189
- By:
- Publication type:
- Article
Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—<italic>Post‐hoc</italic> analysis of a community‐randomized clinical trial (II).
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 12, p. 2491, doi. 10.1002/ijc.31281
- By:
- Publication type:
- Article